For over 75 years, Ochsner has been dedicated to cancer research and new cancer treatment development. We bring innovation to the fight against cancer – including more clinical trials than anywhere else in the region. Each year we enroll more than 1,100 patients in clinical research trials, including some of the world’s most cutting-edge investigational therapies.
The Ochsner Cancer Institute’s highly trained surgeons, medical oncologists, radiation oncologists, nurses, pathologists, scientists, social workers, dieticians and other clinicians provide not only expert clinical care but also the compassionate support every patient needs as they battle cancer. Combining clinical expertise, research leadership and a patient-centered culture, Ochsner’s multidisciplinary approach is broad and holistic, improving outcomes and outlooks for thousands of cancer patients each year.
In 2018, Ochsner Health System was recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program for meeting nationally recognized standards for high-quality cancer care.
U.S. News & World Report ranked Ochsner Medical Center as high performing in cancer care for 2018.
Ochsner’s specialists treat more than 32,000 cancer patients annually, from all 50 states and 28 countries.
Ochsner currently offers more than 150 cancer trials, many of which are unique to Ochsner.
2018 Annual Report 
